Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preventing Contrast Induced Nephropathy After Transcatheter Aortic Valve Replacement

NCT03121053 is registered in ClinicalTrials.gov with St. Antonius Hospital as lead sponsor.

NCT NCT03121053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03121053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preventing Contrast Induced Nephropathy After Transcatheter Aortic Valve Replacement
Lead sponsor
St. Antonius Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2016
Completion date
January 31, 2019
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, aortic valve disease, chronic kidney disease, contrast induced nephropathy